Jason Ptacek
About Jason Ptacek
Jason Ptacek serves as the Director of Translational Science and Biomarkers at Bolt Biotherapeutics, Inc., where he has worked since 2024. He possesses extensive expertise in immuno-oncology and biomarker characterization, with a strong background in various scientific techniques.
Work at Bolt Biotherapeutics
Jason Ptacek currently serves as the Director of Translational Science and Biomarkers at Bolt Biotherapeutics, Inc., a position he has held since 2024. Prior to this role, he was the Associate Director of Translational Science and Biomarkers at the same company, starting in 2022. His work focuses on the characterization of biomarkers in the tumor microenvironment, utilizing both novel and established technologies. Bolt Biotherapeutics is located in Redwood City, California, where Ptacek has contributed to advancing the company's research initiatives.
Education and Expertise
Jason Ptacek earned his Ph.D. in Molecular Biophysics and Biochemistry from Yale University, where he studied from 2000 to 2006. He furthered his education at Stanford University, completing a Postdoctoral Fellowship in Immunology from 2007 to 2010. Ptacek possesses extensive expertise in immuno-oncology and autoimmunity, with a strong emphasis on assay development and complex analysis plans. His technical skills include immunohistochemistry, flow cytometry, RNA sequencing, and proteomics.
Background
Before joining Bolt Biotherapeutics, Jason Ptacek held various positions in the field of translational science. He worked at IONpath Inc. as Associate Director of Research Services from 2019 to 2022 and as Research Services Group Leader from 2016 to 2022. His earlier experience includes roles at BioSeek, a division of DiscoverX, where he served as Senior Scientist and later as Cell Program Group Leader from 2014 to 2016. Ptacek began his academic career as a Graduate Student at Yale University from 2000 to 2006.
Achievements
Throughout his career, Jason Ptacek has been recognized for his contributions to the field of translational science and biomarker research. He is known for his ability to leverage precious clinical samples for research purposes and for his dedication as a team player and leader. His work has significantly advanced the understanding of the tumor microenvironment and its implications for immuno-oncology.